Unlocking the potential of mRNA for the future treatment of rare diseases
Drug Discovery World
FEBRUARY 28, 2023
At this stage, qPCR can be used to check for IVT efficiency, residual DNA contamination and adventitious agents such as microbes. Recent progress on mRNA therapeutics – with at least five programmes in clinical studies – is encouraging, and I hope that we will only see more scientific advancement in the years to come.
52 
Let's personalize your content